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Objective: Assessment of the available evidence regarding
the effect of augmented feedback on motor function of the
upper extremity in rehabilitation patients.
Methods: A systematic literature search was performed to
identify randomized controlled trials that evaluated the
effect of augmented feedback on motor function. Two re-
viewers systematically assessed the methodological quality
of the trials. The reported effects were examined to evaluate
the effect of therapeutic interventions using augmented
feedback and to identify a possible relationship with patient
characteristics, type of intervention, or methodological
quality.
Results: Twenty-six randomized controlled trials were
included, 9 of which reported a positive effect on arm func-
tion tests. Follow-up measurements were performed in 8
trials, 1 of which reported a positive effect. Different thera-
peutic interventions using augmented feedback, i.e. electro-
myographic biofeedback, kinetic feedback, kinematic
feedback, or knowledge of results, show no difference in
effectiveness.
Conclusion: No firm evidence was found of effectiveness
regarding the use of augmented feedback to improve motor
function of the upper extremity in rehabilitation patients.
Future studies should focus more on the content, form and
timing of augmented feedback concerning the therapeutic
intervention. It should be emphasized that motor learning
effects can only be determined by re-examining the popu-
lation after a follow-up period.
Key words: biofeedback, knowledge of results, motor skills,
upper extremity, arm.
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INTRODUCTION
Feedback, along with practice, is considered to be a potent
variable affecting motor skill learning (1, 2). When one performs
a task, there are 2 general types of performance-related infor-
mation, or feedback, available. One type of feedback is called
“task-intrinsic” (or inherent) feedback, which is the sensory-
perceptual information that is a natural part of performing a
skill. For example, a person sees that he has missed picking up
a cup with his hands. The second type of feedback is called
“augmented” feedback. Although various terms have been
used to identify this type of feedback (information, extrinsic
or artificial feedback), the term that will be used in this review
is augmented feedback. “Augmented” refers to adding to or
enhancing task-intrinsic feedback with an external source (2, 3).
The external source may be a therapist or a device such as
a biofeedback system or a timer. This review focuses on the
influence of augmented feedback on the performance and
learning of motor skills.
Augmented feedback has been the focus of a large body of
research (see Salmoni et al. (4) and Winstein (5) for reviews)
and provides a fundamental cornerstone for motor learning
theories. Substantial work has been conducted in which the
effects of feedback variations such as content, form and timing
have been studied (2, 3). Most of the research on which we base
our knowledge of augmented feedback comes from laboratory
experiments in which researchers gave augmented feedback
to young, healthy participants. Typical tasks involved in these
studies were simple and very contrived.
Augmented feedback, properly employed, may have practical
implications for rehabilitation therapy since the re-acquisition
of motor skills is an important part of functional motor recovery
(5, 6). Some patients with cognitive and perceptual impairments
are not able to use intrinsic feedback to guide their performance
(7). Furthermore, because their own abilities to generate
intrinsic feedback may be compromised by neurological sensory
impairments, they may be more dependent on augmented
feedback (8). However, a rehabilitation professional may find
it difficult to implement the motor learning principles due to
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problems with generalizing the laboratory-based motor learning
studies into a clinical setting (9).
Within the rehabilitation setting, therapeutic interventions are
often aimed at improving motor function of the upper extremity.
For example, loss of function of the affected upper extremity is a
major problem after stroke (10). Also, patients with Parkinson’s
disease experience persistent difficulties with motor function of
the upper extremity (11).
In recent decades, a number of articles have been published
in which the effect of various rehabilitation methods using
augmented feedback to improve arm function has been evalu-
ated. Apart from many clinical studies of varying designs,
several attempts have been made to synthesize the findings in
reviews and meta-analyses. Most of these focus on 1 specific
therapeutic intervention, such as EMG biofeedback (12–14).
However, the present review focussed on the augmented feed-
back underlying a diversity of therapeutic interventions.
This present systematic review was performed to address the
following research questions:
! What is the effect of therapeutic interventions using
augmented feedback on motor function of the affected upper
extremity in rehabilitation patients?
! Is there a relationship between the reported effects and
patient characteristics, type of intervention, or methodo-
logical quality?
METHODS
Computerized literature searches were performed using MEDLINE
(1966 – December 2004), EMBASE (1974 – December 2004), and
Cochrane Controlled Trials Register (Cochrane Library Issue 1, 2004).
The specialist rehabilitation research databases CIRRIE (Center for
International Rehabilitation Research Information and Exchange;
1990 – December 2004) and REHABDATA (1956 – December 2004)
were also searched. The CIRRIE database contains citations of inter-
national rehabilitation research. REHABDATA is an extensive database
of disability and rehabilitation literature abstracts. The following key
words were used: feedback, biofeedback, knowledge of results, re-
inforcement, cues, knowledge of performance, upper extremity, arm,
upper limb, rehabilitation. The MEDLINE search strategy is outlined
in Appendix 1. In addition, references to relevant publications were
hand-searched.
Two reviewers (HvD and MJAJ) screened the titles and abstracts of
the results of the literature searches independently. Trials that met the
following criteria were included in the review:
! Therapeutic intervention applied to improve the motor function of
the affected upper extremity in rehabilitation patients.
! Therapeutic intervention using augmented feedback.
! Outcomes measured at impairment and/or disability level.
! Randomized controlled trial (RCT).
! Published, full-length publication.
This systematic review only included RCTs because these are
considered to have the most robust study design with the least risk of
biased results. The reviewers did not apply any language restriction.
The publications that appeared to meet the inclusion criteria were
retrieved and full-length publications were reviewed in further detail. In
a consensus meeting, the 2 reviewers made the final decision on whether
or not a publication should be included in the final review. In cases of
disagreement, consensus was reached by discussion or, if necessary, by
consulting a third reviewer (HJH).
The methodological quality of each included trial was assessed. A
standardized quality scoring form (the Delphi list) containing 9 criteria
was used to assess the randomization, treatment allocation, compar-
ability between groups, eligibility criteria, blinding (of outcome assessor,
care provider and patient), point estimates and measures of variability,
and intention-to-treat analysis (see Appendix 2) (15). The 9 criteria could
be rated as “do not know” if the available information was unclear or
insufficient. If the available information was sufficiently clear, criteria
were rated as “yes”, indicating adequate methods, or “no”, indicating
inadequate methods or potential bias. Each “yes” was scored as 1 point,
and therefore, a maximum of 9 points was possible.
The 2 reviewers (HvD and MJAJ) independently extracted data
(methodological quality criteria, patient characteristics, type of inter-
vention, outcome measures, and reported effects in the original publi-
cations) using a structured form. Blinding of the reviewers was not
considered feasible because both reviewers already had considerable
knowledge of the literature included in the review. Any differences of
opinion were resolved by discussion or by the assistance of the third
reviewer (HJH). Tables describing the included trials were generated.
If necessary, trialists were contacted and requested to supply missing
data. Concerning the therapeutic intervention, 4 different types of
augmented feedback were reported: biofeedback, kinetic feedback,
kinematic feedback and knowledge of results. The term biofeedback
(BF) refers to an augmented form of feedback related to the activity
of physiological processes within the body such as muscle activity
(electromyographic (EMG) biofeedback) (2, 3). A detailed description
of the movement pattern or response dynamics requires kinetic and/or
kinematic feedback. Kinetic feedback parameters are obtained from the
units of mass, force and time and often include impulse and peak force
measures. Kinematic feedback parameters are derived from the dimen-
sions of length and time and common kinematic parameters include
displacement, velocity and acceleration values (16). Knowledge of
results (KR) is a score presented to the performer as a representation
of the outcome of the movement (2–4). This score often represented
the error discrepancy between the performer’s obtained response and
some externally defined goal, although it can also be a representation
of the actual outcome obtained.
The result of each trial was summarized as either “þ ” (positive
for the experimental group, p # 0.05) or “0” (no difference, p $ 0.05),
according to the results presented in the original publications. In case of
more than 1 reported effect (e.g. the experimental intervention consists
of more than 1 group) the reviewers selected the most relevant com-
parison of groups according to the research question. An attempt was
made to identify a relationship between reported effects and the
following variables: patient characteristics (different diagnoses), type of
intervention (different types of augmented feedback) and 2 methodo-
logical characteristics that have been shown to cause bias in the results of
earlier reviews (concealed allocation of treatment and blinding of the
outcome assessor) (17, 18).
RESULTS
The systematic search of the literature resulted in the identifi-
cation of 33 publications, 27 of which fulfilled the selection
criteria and were included in the present review (19–45). Six
publications were excluded because these trials were not ran-
domized. (A list of the excluded articles can be obtained on
request from the first author.) In the 27 publications included in
the review, 26 RCTs were described. The study characteristics
and the methodological scores rated by the present reviewers
are presented in Table I.
The number of patients included in a trial ranged from 9 (35)
to 132 (40, 41). In 18 trials (19–23, 25–28, 32, 33, 35, 37, 39–41,
43–45), the study population concerned stroke patients. Other
study populations were patients with traumatic brain injury
(TBI) (24, 37, 45), spinal cord injury (SCI) (29–31), Parkinson’s
disease (PD) (34, 36, 38) and cerebral palsy (CP) (42). Platz et al.
(36) used healthy subjects as controls.
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The type of therapeutic intervention varied between trials.
Effects of EMG BF (19–21, 25, 27–32, 35, 38–41, 43–45),
kinetic feedback (22, 33), kinematic feedback (23, 26) and KR
(24, 34, 36, 37, 42) were described. In 4 trials, electrical
stimulation (ES) was used to support the therapeutic inter-
vention using augmented feedback; 3 were in addition to the
EMG BF (29–31); 1 in addition to kinematic feedback (23). In 4
trials (19, 25, 27, 32), the experimental intervention EMG BF
was simulated by offering the control group placebo EMG BF.
In most trials, 2 or more different outcome measures were
applied (Table I). Five trials (26, 32, 34, 38, 42) only used 1
outcome measure (relevant for the upper extremity) to deter-
mine the effect of the experimental intervention. The most
frequently used outcome measures were active (19, 23, 27,
28, 35, 44, 45) and/or passive (27, 43, 44) range of motion
(ROM – 10 times) and EMG activity (7 times) (19, 27, 30, 32,
35, 44, 45). It was not always clear what the primary outcome
measure was.
There was a disagreement between the 2 reviewers on 13 out
of 234 (5.6%) of the items assessing the methodological quality.
Consensus on these items was reached by discussion between
the 2 reviewers, so the third reviewer was not consulted.
The scores for methodological quality ranged from 3 (24, 32,
35, 39) to 7 (19) out of 9 possible points. In all trials, a method of
randomization was performed (although concealed allocation
was only reported in 3 trials) (19, 37, 40, 41) and the eligibility
criteria were specified. Groups were not similar (or the available
information was unclear or insufficient) at baseline in 6 trials
(22–24, 32, 35, 39). The outcome assessor was not blinded in
11 trials (22, 24, 26, 29, 32, 35, 36, 38, 42, 44, 45). In none of
the trials was the care provider blinded. The blinding of patients
was performed in 4 trials with the use of simulated/placebo
EMG BF (19, 25, 27, 33). Point estimates and measures of
variability were not presented for the primary outcome measures
in 6 trials (23, 28, 30–32, 39). None of the trials described an
intention-to-treat analysis.
The relationship between 4 study characteristics and reported
effects (either summarized as “þ ” or “0”) on motor function
of the upper extremity is presented in Table II. These study
characteristics are patient characteristics, type of intervention
and the methodological characteristics concealed allocation of
treatment and blinding of the outcome assessor. In 4 trials of the
26 RCTs, the obtained effects were not reported because no
(relevant) statistical test was applied (24, 39) or the augmented
feedback was used in both experimental and control group
(36, 45). Follow-up measurements were performed in 8 trials
(21, 22, 25, 33, 34, 37, 40–42).
Additionally in Table II, the contrast in duration of the
exercise treatments was presented. In 7 trials (22, 23, 27, 29, 38,
40, 41, 43), there was a contrast in the duration of the exercise
treatment between the experimental (E) and received control (C)
intervention for the most relevant comparison of groups. In 3 of
these 7 trials (23, 27, 40, 41), the reported result was positive
in favour of the more intensive treatment. In 6 trials out of 15
(19, 25, 28, 33, 34, 42) without such a contrast in the duration
of treatment, a positive effect for the therapeutic intervention
was reported.
Table II shows there is no relationship between the reported
effects and patient characteristics or type of intervention. Based
on the distribution of the 22 RCTs according to the method-
ological criteria of concealment allocation and blinding the
outcome assessor, there is no reason to suspect that the results
were biased.
DISCUSSION
In this systematic review, the results of 26 RCTs were analysed
in order to assess the effect of therapeutic interventions using
augmented feedback on motor function of the affected upper
extremity in rehabilitation patients and to identify a possible
relationship between the reported effects and patient character-
istics (different diagnoses), type of intervention (different types
of augmented feedback) or methodological quality.
With regard to the first research question, the findings of this
systematic review do not enable a definitive conclusion to be
drawn about the effectiveness of therapeutic interventions using
augmented feedback to improve upper extremity function in
rehabilitation patients. Nine RCTs (19, 23, 25, 27, 28, 33, 34,
40–42) showed a positive (short-term or long-term) effect
between treatment groups in favour of the applied intervention
using augmented feedback and thirteen (20–22, 26, 29–32, 35,
37, 38, 43, 44) showed no difference between the applied
interventions.
Several forms of bias could have influenced the results of the
various trials, indicating that the results should be interpreted
with caution. Firstly, a contrast in the duration of the exercise
treatment is known to bias the results in favour of the more
intensive treatment (46). There was a contrast in the duration
of the treatment in 7 trials (22, 23, 27, 29, 38, 40, 41, 43), 3 of
which (23, 27, 40, 41) reported a positive effect. This positive
result is attributed to augmented feedback, but it might also
be the result of longer duration of the treatment. Secondly, the
results of this review might be biased due to the incompleteness
of the intervention characteristics. Although the reviewers
explicitly tried to extract this data using a structured form, the
content, form and timing of the augmented feedback concerning
the different types of intervention could often not be explored
due to insufficient reported information. Motor learning research
has proven that these factors have great influence on the
performance and learning of motor skills (2, 3).
Motor skill learning can be defined as a set of internal
processes associated with practice or experience leading to a
relatively permanent change in the capability for movement
(2, 3, 5). This rules out the changes in motor skills that can
come from a variety of temporary performance factors. It
is therefore remarkable about the presented trials that only 8
RCTs (21, 22, 25, 33, 34, 37, 40–42) performed a follow-up
measurement to determine if the improvement in motor function
of the upper extremity lasted after a period of non-therapy. Of
these 8, only the study of Marchese et al. (34) showed a positive
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motor learning effect (i.e. a relatively permanent effect after
a period of non-therapy) of the experimental intervention
(using KR) in comparison with the control group. In this study,
the clinical improvements in the “non-cued” group had faded at
6 weeks post-treatment, while in the experimental “cued” group
the improvements still endured. Four of the 8 RCTs (25, 33, 41,
42) showed a lack of persistence of the gained difference
between the treatment groups. This might be caused by short,
low-intensity treatment periods. For a therapeutic intervention
to be fully effective, the treatment/therapy has to be of sufficient
duration and intensity (46).
With regard to the second research question, no firm re-
lationship could be identified between the reported effects and
patient characteristics or type of intervention. Identification of
groups of patients, who might be more likely to benefit from
a specific type of intervention, was difficult because of the
heterogeneity of the trials. Different types of interventions
using augmented feedback, i.e. EMG BF, kinetic feedback,
kinematic feedback, or KR, have shown no difference in
effectiveness.
Meta-analysis is a statistical technique for increasing the
power of the clinical outcome data by pooling individual trial
outcomes (47). It was not possible to perform a meta-analysis of
the findings of different RCTs resulting in a single summary
effect size. The selected trials were too heterogeneous with
regard to patient characteristics and type of intervention. It was
therefore decided to refrain from performing a pooled analysis
in this review. Moreover, the focus of the present review was
on the augmented feedback underlying the therapeutic inter-
vention. The heterogeneity of the included trials was expected
as the inclusion criteria did not focus on patient diagnosis or
therapeutic intervention. Concerning the specific therapeutic
intervention EMG BF 3 meta-analyses are available that
assessed the efficacy of biofeedback therapy in post-stroke
rehabilitation (12–14).
Regarding the methodological quality of the included RCTs
in relation to the reported effects, it is noticeable that the
methodological score (rated by the 2 reviewers) is slightly
higher for the trials reporting a positive effect in favour of the
experimental treatment in comparison to the trials reporting
a negative effect (i.e. mean score of 5.2 for trials reporting a
positive effect and 4.2 for trials reporting a negative effect).
This higher score is largely attributable to the blinding of the
outcome assessor (Table II). One might expect that blinding
the outcome assessor decrease the opportunity for a positive
effect to occur since the assessor is likely to favour the experi-
mental treatment. This is however not the case in the present
review. The authors did not find an explanation for this.
The methodological scores are generally low (a score of 3 or
4 out of 9) for the majority of the included trials (15 trials out
Table II. Relationship between reported effects of the augmented feedback on arm function and study characteristics
References
Reported
effecta
Contrast in
duration of
treatmentb
Patient
characteristics
Type of
intervention
Concealment
of allocationb
Blinding of
outcome
assessorb
Shumaker, 1980 (38) 0 þ PD EMG BF % %
Klose et al., 1993 (29) 0 þ SCI EMG BF % %
Klose et al., 1990c (30) 0 % SCI EMG BF % þ
Kohlmeyer et al., 1996d (31) 0 % SCI EMG BF % þ
Basmaijan et al., 1982 (20) 0 % Stroke EMG BF % þ
Basmaijan et al., 1987 (21) PT0, FU0 % Stroke EMG BF % þ
Lee et al., 1976 (32) 0 % Stroke EMG BF % %
Mroczek et al., 1978 (35) 0 % Stroke EMG BF % %
Williams, 1982e (43) 0 þ Stroke EMG BF % þ
Wolf et al., 1994 (44) 0 % Stroke EMG BF % %
Bourbonnais et al., 2002 (22) PT0, FU0 þ Stroke Kinetic feedback % %
Greenberg and Fowler, 1980 (26) 0 % Stroke Kinematic feedback % %
Platz et al., 2001e (37) PT0, FU0 % Stroke and TBI KR þ þ
Armagan et al., 2003 (19) þ % Stroke EMG BF þ þ
Hurd et al., 1980f (27) þ þ Stroke EMG BF % þ
Inglis et al., 1984 (28) þ % Stroke EMG BF % þ
Sunderland et al., 1992, 1994 (41, 40) PT0, FU0 þ Stroke EMG BF þ þ
Crow et al., 1989 (25) PT0, FU0 % Stroke EMG BF % þ
Lum et al., 2002 (33) PT0, FU0 % Stroke Kinetic feedback % þ
Bowman et al., 1979 (23) þ þ Stroke Kinematic feedback % þ
Talbot and Junkala, 1981g (42) PT0, FU0 % CP KR % %
Marchese et al., 2000 (34) PT0, FUþ % PD KR % þ
a Effect reported in original publication on outcome measure selected as primary by the authors/reviewers; PT = post-test; FU = follow-up.
b “þ ” means yes; “%” means no/do not know.
c E1 and E2 compared with C.
d E1 and E3 compared with C.
e E1 compared with E2.
f E compared with C2.
g E compared with C1.
PD = Parkinson’s disease; SCI = spinal cord injury; TBI = traumatic brain injury; CP = cerebral palsy; EMG BF = electromyographic
biofeedback; KR = knowledge of results.
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of the total of 26 trials). Future studies should more consider
the concealment of treatment allocation, the blinding of care
providers and patients, and an intention-to-treat analysis as
design requirements.
Although augmented feedback is widely regarded as a critical
variable in the (re)acquisition of motor skills, no firm evidence
was found of the effectiveness of the use of augmented feedback
to improve arm function in rehabilitation patients in the present
review. This does not imply evidence of no effect. Winstein (5)
suggested that it is appropriate to use the principles of motor
learning obtained through laboratory experimentation as guide-
lines when applying basic research findings to clinical practice.
However, given the insufficient reported information in the
included publications, it is not yet possible to formulate to what
extent these principles of motor learning (regarding the use of
augmented feedback) are properly employed. Future studies
should focus more on the content, form and timing of the
augmented feedback in order to clarify its importance. Also,
more studies should recognize the difference between perfor-
mance and learning effects concerning the (re)acquisition of
motor skills by re-examining the study population after a
follow-up period.
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APPENDIX 1
MEDLINE search strategy
#1 Feedback [MeSH]
#2 Biofeedback [MeSH]
#3 Knowledge of results [MeSH]
#4 Reinforcement [MeSH]
#5 Cues [MeSH]
#6 Knowledge [tw] AND Performance [tw]
#7 Upper extremity [MeSH]
#8 Arm [MeSH]
#9 Upper limb [tw]
#10 Rehabilitation [MeSH]
#11 #1 OR #2 OR #3 OR #4 OR #5 OR #6
#12 #7 OR #8 OR #9
#13 #10 AND #11 AND #12 AND Randomized controlled
trial [pt]
#14 #13 AND Human [MeSH]
APPENDIX 2
The Delphi list
1. Was a method of randomization performed?
2. Was the treatment allocation concealed?
3. Were the groups similar at baseline regarding the most
important prognostic indicators?
4. Were eligibility criteria specified?
5. Was the outcome assessor blinded?
6. Was the care provider blinded?
7. Was the patient blinded?
8. Were point estimates and measures of variability presented
for the primary outcome measures?
9. Did the analysis include an intention-to-treat analysis?
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